Tiffany Reiter, Ph.D., focuses her practice on U.S. and foreign patent prosecution, opinion work, due diligence studies, and patent portfolio development.
Tiffany has extensive experience prosecuting patents for life sciences innovations including:
Molecular biology and cellular biology
Biochemistry and biochemical pathways
Genetics
Virology
Recombinant protein manufacturing
Nucleic acid vectors and RNAi
Chromatin remodeling
Array technology
Immunology
Recombinant antibody screening and engineering
Molecular medicine
Screening and diagnostic assays and kits
Biomarkers
Transgenic plants and animals
Cell lines
Nanoparticle technology
Surgical procedures, vaccines, and neuroscience
She also drafts patentability and infringement opinions regarding these technologies, conducts extensive due diligence investigations to uncover infringement risks, and guides clients in building commercially valuable global patent portfolios.
As a post-doctoral fellow at the Harvard School of Public Health, Tiffany gained research experience working on a project combining the fields of neuroscience, molecular biology, and biochemistry. As an intern at Northrup King, she worked on transgenic plant research, and as a student at the Mayo Graduate School, she studied the redox regulation of metalloenzymes using molecular biology, cellular biology, biochemistry, and a variety of spectroscopic methods.
Tiffany's interests include archeology, anthropology, gardening, and mystery fiction.